{"transactions":[{"id":3681506,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":160755,"kind":"person","name":"Weiland Robert J.","position":1,"cik":"0001670648","reported_name":"Weiland Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-31T17:23:35.000Z","date":"2019-01-29","kind":"grant","acquired":true,"shares":27705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the underlying shares monthly from January 1, 2019."}],"balance_after":27705,"derivative":{"exercise_price":8.43,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":27705},"source":{"system":"sec-edgar","filing":"0001333277-19-000024","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000133327719000024/edgar.xml","form_type":"4"}},{"id":3903494,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":160755,"kind":"person","name":"Weiland Robert J.","position":1,"cik":"0001670648","reported_name":"Weiland Robert J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2018-06-06T20:11:05.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":373,"price":33.02,"value":12316.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 339 and 258 shares of common stock acquired under the issuer's employee stock purchase plan in June 2017 and December 2017, respectively."}],"balance_after":5088,"source":{"system":"sec-edgar","filing":"0001209191-18-036185","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670648/000120919118036185/doc4.xml","form_type":"4"}},{"id":4088453,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":160755,"kind":"person","name":"Weiland Robert J.","position":1,"cik":"0001670648","reported_name":"Weiland Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-26T17:46:10.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the underlying shares monthly beginning January 1, 2018."}],"balance_after":16000,"derivative":{"exercise_price":11.69,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001333277-18-000032","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000133327718000032/edgar.xml","form_type":"4"}},{"id":4201682,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":160755,"kind":"person","name":"Weiland Robert J.","position":1,"cik":"0001670648","reported_name":"Weiland Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-26T09:39:40.000Z","date":"2017-09-22","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 12 equal monthly installments commencing on June 1, 2017, subject to the Reporting Person's continuous service to the Issuer as of each such date. The option allows for early exercise by the Reporting Person."}],"balance_after":7500,"derivative":{"exercise_price":7.47,"expiration_date":"2027-09-21","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-17-053902","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000120919117053902/doc4.xml","form_type":"4"}},{"id":4269477,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":160755,"kind":"person","name":"Weiland Robert J.","position":1,"cik":"0001670648","reported_name":"Weiland Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-30T14:35:54.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 12 equal monthly installments commencing on June 1, 2017."}],"balance_after":15000,"derivative":{"exercise_price":5.5,"expiration_date":"2027-06-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001042074-17-000013","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000104207417000013/primary_doc.xml","form_type":"4"}},{"id":4279397,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":160755,"kind":"person","name":"Weiland Robert J.","position":1,"cik":"0001670648","reported_name":"Weiland Robert J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-16T20:08:43.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":9000,"derivative":{"exercise_price":44.2,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-17-040685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1670648/000120919117040685/doc4.xml","form_type":"4"}},{"id":4279396,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":160755,"kind":"person","name":"Weiland Robert J.","position":1,"cik":"0001670648","reported_name":"Weiland Robert J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-06-16T20:08:43.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 364 shares of common stock acquired under the issuer's employee stock purchase plan in December 2016."}],"balance_after":4864,"source":{"system":"sec-edgar","filing":"0001209191-17-040685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670648/000120919117040685/doc4.xml","form_type":"4"}},{"id":4484253,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":160755,"kind":"person","name":"Weiland Robert J.","position":1,"cik":"0001670648","reported_name":"Weiland Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-01-23T18:33:02.000Z","date":"2017-01-19","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three annual installments from the vesting start date of January 19, 2017."}],"balance_after":12000,"derivative":{"exercise_price":1.72,"expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001179110-17-001194","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000117911017001194/edgar.xml","form_type":"4"}},{"id":4527138,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":160755,"kind":"person","name":"Weiland Robert J.","position":1,"cik":"0001670648","reported_name":"Weiland Robert J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-09T20:27:07.000Z","date":"2016-12-07","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":16000,"derivative":{"exercise_price":32.35,"expiration_date":"2026-12-07","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-16-154560","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670648/000120919116154560/doc4.xml","form_type":"4"}}]}